What treatments are available for sarcoidosis? 

Sarcoidosis is a medical condition that involves the immune system creating small, inflamed clusters of tissue known as granulomas in different parts of the body. While the condition can be concerning, the approach to treatment in the United Kingdom is highly personalised and depends heavily on which organs are affected and how much the inflammation is impacting a person’s daily life. Because the body often manages this inflammation naturally, the “treatment” for many patients is not medication, but careful monitoring by a medical team to ensure the condition settles safely without causing long term tissue damage. 

What We’ll Discuss in This Article 

• Why many people diagnosed with sarcoidosis do not require immediate medication. 

• The role of corticosteroids as the primary medical treatment for active disease. 

• The use of second-line immunosuppressant drugs as steroid-sparing agents. 

• Advanced biological therapies like infliximab for severe or refractory cases. 

• Topical treatments such as eye drops and skin creams for localised symptoms. 

• Lifestyle measures and supportive care to manage symptoms like fatigue. 

• A comparison table of the different levels of medical intervention. 

The standard approach of monitoring and observation 

For a significant number of people, the most appropriate treatment for sarcoidosis is simply to monitor the condition through regular check ups and tests. This is often referred to as “watchful waiting” because clinical evidence shows that in many cases, the granulomas will shrink and disappear on their own without the need for strong medication. If you have no symptoms or only very mild ones, and your organ function remains stable, your medical team will likely choose to observe your progress rather than start a course of drugs that could cause side effects. 

During this period, you will typically have regular chest X-rays, blood tests to check calcium levels and organ function, and breathing tests to ensure your lung capacity remains healthy. According to NHS guidance, most people with sarcoidosis find that their symptoms have disappeared within a few years of their diagnosis. This observation-led approach is designed to allow the body to heal naturally while ensuring that any changes in the disease are caught early so that medical treatment can be introduced if it becomes necessary. 

First-line medical treatment with corticosteroids 

If sarcoidosis begins to affect the function of vital organs or if symptoms become significantly disruptive, the first medical treatment usually prescribed is a course of corticosteroids. The most common form used in the UK is a tablet called prednisolone, which works by dampening the immune system’s overactive response and reducing the swelling of the granulomas. This helps to relieve symptoms like breathlessness and prevents the formation of permanent scar tissue within the organs. 

Treatment typically starts with a higher dose of prednisolone to “switch off” the inflammation, which is then gradually reduced or tapered over several months as the condition stabilises. While effective, corticosteroids can cause side effects if taken in high doses for a long time, such as weight gain, mood changes, increased blood sugar, and a higher risk of thinning bones. Because of these potential issues, doctors always aim to use the lowest effective dose for the shortest time possible, and they may recommend supplements like calcium and vitamin D to protect bone health while you are on the medication. 

Second-line and steroid-sparing medications 

When corticosteroids are not enough to control the disease, or if a patient experiences significant side effects from steroids, second-line medications known as immunosuppressants or “steroid-sparing agents” are used. These drugs allow the dose of steroids to be reduced or stopped entirely while still keeping the inflammation under control. The most frequently used second-line treatment in the UK is methotrexate, which is typically taken as a single dose once a week alongside a folic acid supplement to reduce potential side effects. 

Other immunosuppressant options include azathioprine, mycophenolate, and leflunomide. These medications work differently from steroids by more specifically targeting the cells in the immune system that are causing the inflammation. Because these drugs can affect the liver or blood cell counts, patients must have regular blood test monitoring while taking them. NICE standards indicate that these treatments are generally managed by specialists in secondary care to ensure they are used safely and effectively over the long term. 

Biological therapies for refractory sarcoidosis 

In rare cases where first and second-line treatments have not been successful, advanced medications called biological therapies may be considered. These treatments, such as infliximab or adalimumab, are types of monoclonal antibodies that target specific proteins in the immune system called tumour necrosis factor (TNF) alpha. These proteins are known to play a key role in the development and persistence of granulomas in sarcoidosis. 

Infliximab is administered as an intravenous infusion in a hospital setting, usually once every few weeks after an initial loading period. This treatment is generally reserved for patients with severe, “refractory” disease that has not responded to other options, or for those who have life-threatening involvement of the heart or nervous system. Recently, NHS England has updated its commissioning policies to make these advanced biological treatments more accessible for specific groups of patients who meet strict clinical criteria. 

Localised and topical treatment options 

For some individuals, sarcoidosis may only affect specific areas like the skin or the eyes, meaning that systemic medication in the form of tablets is not always required. In these instances, localised treatments can be highly effective at managing inflammation without impacting the rest of the body. For cutaneous sarcoidosis, where the skin is involved, steroid creams or gels are often applied directly to the affected patches to reduce redness and swelling. 

Ocular sarcoidosis, which affects the eyes, is frequently managed with corticosteroid eye drops to treat inflammation like uveitis. These drops help to maintain vision and prevent complications like glaucoma or cataracts. If the inflammation is deeper within the eye, a specialist might recommend local injections or a combination of topical and systemic treatment. These localised approaches allow for high concentrations of medication to reach the target area while minimising the risk of side effects associated with tablets. 

Lifestyle measures and supportive care 

Beyond medical prescriptions, certain lifestyle choices and supportive care measures can help individuals manage the daily symptoms of sarcoidosis and support their body’s recovery. Maintaining a healthy, balanced diet and achieving a healthy weight can help reduce the overall load on the heart and lungs. Regular gentle exercise, as tolerated, is also beneficial for maintaining muscle strength and supporting general well-being. 

Stopping smoking is perhaps the most important lifestyle change for anyone with sarcoidosis, as it reduces irritation in the lungs and helps preserve respiratory function. Many patients also find that managing stress and ensuring they get enough sleep helps with the profound fatigue that often accompanies the condition. Simple over-the-counter painkillers like paracetamol or ibuprofen can also be used to manage joint aches and fever, though you should always consult your medical team before starting any new medication. 

Comparison of sarcoidosis treatment levels 

The following table provides a comparison of the different levels of treatment used depending on the severity and location of the disease. 

Treatment Level	Common Medications	Primary Purpose	When it is Used
Observation	None (Monitoring)	To allow natural resolution.	For mild cases with no organ risk.
Localised	Creams, eye drops	To treat specific local areas.	For skin or eye symptoms only.
First-Line	Prednisolone (Steroids)	To rapidly reduce inflammation.	For active disease or organ risk.
Second-Line	Methotrexate, Azathioprine	To spare the use of steroids.	If steroids cause side effects or fail.
Third-Line	Infliximab (Biologics)	To treat resistant disease.	For severe, refractory cases.

Conclusion 

The treatments available for sarcoidosis range from simple clinical observation to advanced biological therapies, ensuring that care is matched to the specific needs of each patient. While many people will not require any medication, those who do have access to effective options like corticosteroids and immunosuppressants to control inflammation and protect their organs. Consistency in monitoring and follow-up care remains the most important factor in achieving a positive long term outcome. 

If you experience severe, sudden, or worsening symptoms, call 999 immediately. This is especially important if you develop sudden difficulty breathing, severe chest pain, or changes in your vision or heart rhythm. 

Authority Snapshot (E-E-A-T Block) 

This article was developed to provide the public with clear and factual information regarding the treatment options for sarcoidosis in the UK. The content is authored and reviewed by UK-trained medical professionals and adheres strictly to the clinical guidance provided by the NHS and NICE. Our priority is ensuring that readers receive safe, evidence-based information that aligns with current UK medical practice.